Connect with NIDA:

Heroin + Opioids + Pain Medication + Prescription Drugs News Releases

Email FacebookTwitter

Co-prescribing naloxone in Medicare Part D increases (August 06, 2019)
Science Spotlight.
NIH establishes network to improve opioid addiction treatment in criminal justice settings (July 24, 2019)
Ten clinical research centers will address gaps in accessing high-quality care.
Project to deter opioid tampering wins 2019 NIDA Addiction Science Award (May 17, 2019)
NIDA announces awardees at the 2019 Intel International Science and Engineering Fair.
National Institute on Drug Abuse Intramural Research Program Holds Opioid Symposium (May 15, 2019)
Media Advisory.
Opioid Dose Variability Associated with Overdose (April 22, 2019)
Science Spotlight.
Opioids without the risk of addiction? (March 26, 2019)
Science Spotlight.
Opioid Overdose Reversal News: FDA-approved naloxone devices produce substantially higher blood levels of naloxone than improvised nasal spray (March 15, 2019)
Science Spotlight.
Monthly buprenorphine injections effective for opioid use disorders (February 19, 2019)
Study results on long-acting injection formulation now published.
Higher rates of NAS linked with economic conditions (January 29, 2019)
Science Spotlight.
Cascade of Care model recommended for opioid crisis (January 25, 2019)
Science Spotlight.
Study shows impact of social interactions on addictive behavior (October 15, 2018)
Science Spotlight.
New opioid treatment resources for emergency department clinicians (October 03, 2018)
Announcement.
Journal commentary addresses role of dentists in opioid crisis (July 25, 2018)
Announcement.
New clinician screening tool available for substance use (June 28, 2018)
Announcement.
Training module now available for acute pain management in hospitalized adults (June 27, 2018)
New online course is 10th in a series developed by the NIH Pain Consortium.
Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications (June 22, 2018)
Science Spotlight.
Methadone and buprenorphine reduce risk of death after opioid overdose (June 19, 2018)
NIH research confirms effective treatments for opioid use disorder are underutilized.
FDA approves first medication to reduce opioid withdrawal symptoms (May 16, 2018)
Announcement.
Study upends conventional view of opioid mechanism of action (May 10, 2018)
NIH-funded scientists find new molecular target for developing safer pain medications.
Nearly half of opioid-related overdose deaths involve fentanyl (May 01, 2018)
Announcement.
Understanding the Neuroscience of Addiction: what it means for prevention and treatment (April 25, 2018)
Announcement.
Five million American adults misusing prescription stimulants (April 16, 2018)
Science Spotlight.
Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release (February 14, 2018)
Science Spotlight.
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development (January 04, 2018)
Science Spotlight.
Cocaine contributes to overdose deaths among some minorities (December 04, 2017)
Science Spotlight.
Separating side effects could hold key for safer opioids (November 16, 2017)
NIH-funded scientists may have revealed brain functions in pre-clinical research that widen the safety margin for opioid pain relief without overdose .
Opioid treatment drugs have similar outcomes once patients initiate treatment (November 14, 2017)
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone.
Study identifies a brain pathway involved in drug relapse after cessation of contingency management (October 11, 2017)
Science Spotlight.
Marijuana use is associated with an increased risk of prescription opioid misuse and use disorders (September 26, 2017)
Science Spotlight.
Collaborative care shows promise for opioid and alcohol use disorders (August 28, 2017)
Science Spotlight.

Pages

Resources for the Media

Featured Publication

NIDA Media Guide

Connecting the scientific community and the media